Improvement of endothelial function in uraemic patients on peritoneal dialysis: A possible role for 5-MTHF administration

Nephrology Dialysis Transplantation

Volumn 22, Issue 11, 2007, Pages 3292-3297

  Baragetti, Ivano ^a,c   Raselli, Sara ^b   Stucchi, Andrea ^a   Terraneo, Veronica ^a   Furiani, Silvia ^a   Buzzi, Laura ^a   Garlaschelli, Katia ^b   Alberghini, Elena ^a   Catapano, Alberico L ^b   Buccianti, Gherardo ^a  

^a Bassini Hospital   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

5 methyltetrahydrofolate; Atherosclerosis; Endothelial function; Peritoneal dialysis; Plasma homocysteine

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ALKADIENE; GLYCERYL TRINITRATE; HOMOCYSTEINE; ICODEXTRIN;

ADULT; ARTICLE; BLOOD LEVEL; BRACHIAL ARTERY; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; HOMOCYSTINURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPEREMIA; KIDNEY FAILURE; MALE; OXIDATIVE STRESS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TOURNIQUET; UREMIA; VASODILATATION;

AGED; DIABETIC NEPHROPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; TETRAHYDROFOLATES; UREMIA; VASODILATION;

EID: 36749035391     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm402     Document Type: Article

References (35)

1. Moat SJ, Doshi SN, Lang D, McDowell IF, Lewis MJ, Goodfellow J. Treatment of coronary heart disease with folic acid: is there a future? Am J Physiol Heart Circ Physiol 2004; 287: H1-H7
2. Francis ME, Eggers PW, Hostetter TH, Briggs JP. Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int 2004; 66: 303-312
3. Moustapha A, Naso A, Nahlawi M et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 1998; 97: 138-141
4. Bostom AG, Shemin D, Verhoef P et al. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. Arterioscler Thromb Vasc Biol 1997; 17: 2554-2558
5. Mallamaci F, Zoccali C, Tripepi G et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 2002; 61: 609-614
6. Buccianti G, Baragetti I, Bamonti F, Furiani S, Dorighet V, Patrosso C. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease. J Nephrol 2004; 17: 405-410
7. Wrone EM, Hornberger JM, Zehnder JL, McCann LM, Coplon NS, Fortmann SP. Randomized trial of folic acid for the prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol 2004; 15: 420-426
8. Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD. A low rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 2004; 15: 442-453
9. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T. Endothelial dysfunction by acute hyperhomocystein (e) mia: restoration by folic acid. Clin Sci 1999; 96: 235-239
10. Bellamy MF, McDowell IF, Ramsey MW, Brownlee M, Newcombe RG, Lewis MJ. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. Eur J Clin Invest 1999; 29: 659-662
11. Verhaar MC, Wever RM, Kastelein JJ et al. Effect of oral folic acid supplementation on endothelial function in familial hypercholesterolemia: a randomized-placebo controlled trial. Circulation 1999; 100: 335-338
12. Title LM, Cummings PM, Giddens K, Genest JJ Jr, Nassar BA. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol 2000; 36: 758-765
13. Kunz K, Petitjean P, Lisri M et al. Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link? Nephrol Dial Transplant 1999; 14: 1934-1942
14. van Guldener C, Janssen MJ, Lambert J, Ter Wee PM, Donker AJ, Stehouwer CD. Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy. Perit Dial Int 1998; 18: 282-289
15. Buccianti G, Raselli S, Baragetti I et al. 5- methyltetrahydrofolate restores endothelial function in uremic patients on convective haemodialysis. Nephrol Dial Transplant 2002; 17: 857
16. Arnadottir M, Gudnason V, Hultberg B. Treatment with different doses of folic acid in haemodialysis patients: effects on folate distribution and aminothiol concentrations. Nephrol Dial Transplant 2000; 15: 524-528
17. Jiang X, Yang F, Tan H et al. Hyperhomocysteinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol 2005; 25: 2515-2521
18. Suliman ME, Barany P, Kalantar-Zadeh K, Lindholm B, Stenvinkel P. Homocysteine in uremia - a puzzling and conflicting story. Nephrol Dial Transplant 2005; 20: 16-21
19. Wrone EM, Hornberger JM, Zehnder JL, McCann LM, Coplon NS, Fortmann SP. Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol 2004; 15: 420-426
20. Zoungas S, McGrath BP, Branley P et al. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol 2006; 47: 1108-1116
21. Loscalzo J. Homocysteine trials - clear outcomes for complex reasons. N Engl J Med 2006; 354: 1629-1632
22. Righetti M, Serbelloni P, Milani S, Ferrario GM. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients. Blood Purif 2006; 24: 379-386
23. Livant EJ, Tamura T, Johnston KE. Plasma folate conjugase activities and folate concentrations in patients receiving hemodialysis. J Nutr Biochem 1994; 5: 504-508
24. Jennette JC, Goldman D. Inhibition of the membrane transport of folates by anions retained in uremia. J Lab Clin Med 1975; 86: 834-843
25. Bostom AG, Shemin D, Bagley P et al. Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients. Circulation 2000; 101: 2829-2832
26. Yango A, Shemin D, Hsu N et al. Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients. Kidney Int 2001; 59: 324-327
27. Hauser AC, Hagen W, Rehak PH et al. Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients. Am J Kidney Dis 2001; 37: 758-765
28. Ducloux D, Aboubakr A, Motte G et al. Hyperhomocysteinemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12. Nephrol Dial Transplant 2002; 17: 865-870
29. van Guldener C, Janssen MJ, Lambert J, ter Wee PM, Donker AJ, Stehouwer CD. Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy. Perit Dial Int 1998; 18: 282-289
30. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend J. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation 2000; 102: 871-875
31. Hyndman ME, Verma S, Rosenfeld RJ, Anderson TJ, Parsons HG. Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. Am J Physiol Heart Circ Physiol 2002; 282: H2167-H2172
32. Antoniades C, Shirodaria C, Werrick N et al. 5- methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 2006; 114: 1193-1201
33. Griffith TM, Chaytor AT, Bakker LM, Edwards DH. 5-methyltetrahydrofolate and tetrahydrobiopterin can modulate electrotonically mediated endothelium-dependent vascular relaxation. Proc Natl Acad Sci USA 2005; 102: 7008-7013
34. van Etten RW, de Koning EJ, Verhaar MC, Gaillard CA, Rabelink TJ. Impaired NO-dependent vasodilation in patients with type II (non-insulin- dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 2002; 45: 1004-1010
35. Doshi SN, McDowell IF, Moat SJ et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002; 105: 22-26